(Q35185005)

7 August 2017

1 reference

title

Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse (English)

1 reference

ORCID Public Data File 2021

7 August 2017

1 reference

1 reference

1 reference

1 reference

author name string

Raffaghello L

1

1 reference

7 August 2017

Marimpietri D

2

1 reference

7 August 2017

Pagnan G

3

1 reference

7 August 2017

Pastorino F

4

1 reference

7 August 2017

Cosimo E

5

1 reference

7 August 2017

Brignole C

6

1 reference

7 August 2017

Ponzoni M

7

1 reference

7 August 2017

Montaldo PG

8

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

7 August 2017

1 reference

7 August 2017

197

1 reference

7 August 2017

1-2

1 reference

7 August 2017

205-209

1 reference

A metastatic neuroblastoma model in SCID mice

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900100-9

7 January 2021

Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900100-9

7 January 2021

Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900100-9

7 January 2021

Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900100-9

7 January 2021

Surface antigen expression and complement susceptibility of differentiated neuroblastoma clones

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900100-9

7 January 2021

Effects of liposome-encapsulated dichloromethylene diphosphonate on macrophage function and endotoxin-induced mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900100-9

7 January 2021

10.1016/S0304-3835(03)00100-9

Identifiers

DOI

1 reference

7 August 2017

1 reference